Obesity drug maker Novo Nordisk ousts CEO as competition weighs
- Posted on May 16, 2025
- By The Globe and Mail
- 2 Views
Obesity drug maker Novo Nordisk ousts CEO as competition weighs
Jorgensen, who has been CEO since 2017, will remain in the role until a new CEO has been appointed, Novo Nordisk said
